 |
 |
|
|
|
| BOLDENONE CYPIONATE |
 |
| BOLDENONE CYPIONATE; 17beta-Hydroxyandrosta-1,4-dien-3-one Cyclopentanepropionate |
 |
| 106505-90-2 |
 |
Effects:
The activity of boldenone is mainly anabolic, with a low androgenic potency.
Boldenone will increase nitrogen retention, protein synthesis, increases appetite and stimulates the release of erythropoietin in the kidneys.
Boldenone was synthesized in an attempt to create a long-acting injectable methandrostenolone (Dianabol), but in reality boldenone acts nothing like methandrostenolone. It has a very long half-life, and can show up on a steroid test for up to 1.5 years, due to the long undecylenate ester attached to the parent steroid. Trace amounts of the drug can easily be detected for months after discontinued use.
|
 |
MF: C26H38O3
MW: 398.58
EINECS: 212-686-0
Assays: £¾99.50%
Packing: as your require
Quality standard: Enterprise Standard
Apperance: off-white crystalline powder
Product Category: Pharmaceutical raw material and intermediates
Content: 97% Boldenone
product description:
Boldenone, available as the undecylenate ester, also known under the trade name Equipoise,Ganabol,Equigan,Ultragan, is an anabolic steroid developed for veterinary use, Boldenone will increase nitrogen retention, protein synthesis,increases appetito and stimulates the release of erythropoietin in the kidneys.
Boldenone was synthetisized in an attempt in an attemp to creat a long-time injectable methandienone(dianabol), in reality boldenone acts nothing like methandrostenolone. It has a very long half-life, and can show up on a steroid test for up to 1.5 years, due to the long undecylenate ester attached to the parent steroid. Trace amounts of the drug can easily be detected for months after discontinued use.
Boldenone produced by my factory has a good quality and competitive price, wellcome to inquiry me Boldenone, I can give you a good guide.
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
